Get started
TORRENT PHARMACEUTICALS LTORRENT PHARMACEUTICALS LTORRENT PHARMACEUTICALS L

TORRENT PHARMACEUTICALS L

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

TORNTPHARM chart


Full chart

TORNTPHARM upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.12 T‬ INR
Dividend yield (indicated)
0.97%
Price to earnings Ratio (TTM)
59.15
Basic EPS (TTM)
56.45 INR
Net income (FY)
‪19.11 B‬ INR
Revenue (FY)
‪113.58 B‬ INR
Shares float
‪105.79 M‬
Beta (1Y)
0.66

Employees


Employees (FY)
‪20.01 K‬
Change (1Y)
‪+1.54 K‬ +8.33%
Revenue / Employee (1Y)
‪5.68 M‬ INR
Net income / Employee (1Y)
‪955.34 K‬ INR

About TORRENT PHARMACEUTICALS L


Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
torrentpharma.com
Headquarters
Ahmedabad
Founded
1959
ISIN
INE685A01028
FIGI
BBG000D80XY7
Torrent Pharmaceuticals Ltd. engages in the research, development, manufacture, and marketing of generic pharmaceutical formulations. It offers pharmaceutical products to local and international markets, particularly in countries such as India, USA, Germany, Brazil, and other countries. The company was founded by Uttambhai Nathalal Mehta in 1959 and is headquartered in Ahmedabad, India.

Check out other big names from the same industry as TORNTPHARM.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

TORNTPHARM news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of TORNTPHARM is 3,314.20 INR — it has decreased by −0.75% in the past 24 hours. Watch TORRENT PHARMACEUTICALS L stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange TORRENT PHARMACEUTICALS L stocks are traded under the ticker TORNTPHARM.
TORNTPHARM stock has fallen by −0.65% compared to the previous week, the month change is a 2.93% rise, over the last year TORRENT PHARMACEUTICALS L has showed a 12.27% increase.
We've gathered analysts' opinions on TORRENT PHARMACEUTICALS L future price: according to them, TORNTPHARM price has a max estimate of 4,160.00 INR and a min estimate of 3,150.00 INR. Watch TORNTPHARM chart and read a more detailed TORRENT PHARMACEUTICALS L stock forecast: see what analysts think of TORRENT PHARMACEUTICALS L and suggest that you do with its stocks.
TORNTPHARM reached its all-time high on Oct 9, 2024 with the price of 3,590.70 INR, and its all-time low was 4.05 INR and was reached on Dec 1, 1998. View more price dynamics on TORNTPHARM chart.
See other stocks reaching their highest and lowest prices.
TORNTPHARM stock is 1.77% volatile and has beta coefficient of 0.66. Track TORRENT PHARMACEUTICALS L stock price on the chart and check out the list of the most volatile stocks — is TORRENT PHARMACEUTICALS L there?
Today TORRENT PHARMACEUTICALS L has the market capitalization of ‪1.12 T‬, it has decreased by −0.75% over the last week.
Yes, you can track TORRENT PHARMACEUTICALS L financials in yearly and quarterly reports right on TradingView.
TORRENT PHARMACEUTICALS L is going to release the next earnings report on Jul 29, 2025. Keep track of upcoming events with our Earnings Calendar.
TORNTPHARM earnings for the last quarter are 15.40 INR per share, whereas the estimation was 14.35 INR resulting in a 7.33% surprise. The estimated earnings for the next quarter are 17.22 INR per share. See more details about TORRENT PHARMACEUTICALS L earnings.
TORRENT PHARMACEUTICALS L revenue for the last quarter amounts to ‪29.59 B‬ INR, despite the estimated figure of ‪29.91 B‬ INR. In the next quarter, revenue is expected to reach ‪31.52 B‬ INR.
TORNTPHARM net income for the last quarter is ‪4.98 B‬ INR, while the quarter before that showed ‪5.03 B‬ INR of net income which accounts for −0.99% change. Track more TORRENT PHARMACEUTICALS L financial stats to get the full picture.
TORRENT PHARMACEUTICALS L dividend yield was 0.99% in 2024, and payout ratio reached 56.67%. The year before the numbers were 1.08% and 57.21% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 13, 2025, the company has ‪20.01 K‬ employees. See our rating of the largest employees — is TORRENT PHARMACEUTICALS L on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TORRENT PHARMACEUTICALS L EBITDA is ‪37.21 B‬ INR, and current EBITDA margin is 32.09%. See more stats in TORRENT PHARMACEUTICALS L financial statements.
Like other stocks, TORNTPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TORRENT PHARMACEUTICALS L stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TORRENT PHARMACEUTICALS L technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TORRENT PHARMACEUTICALS L stock shows the buy signal. See more of TORRENT PHARMACEUTICALS L technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.